Quantitative Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-7,635
| Closed | -$344K | – | 397 |
|
|
2025
Q3 | $344K | Sell |
7,635
-55,763
| -88% | -$2.6M | 0.05% | 265 |
|
|
2025
Q2 | $2.93M | Buy |
+63,398
| New | +$3.11M | 0.39% | 56 |
|
|
2025
Q1 | – | Sell |
-60,952
| Closed | -$3.45M | – | 345 |
|
|
2024
Q4 | $3.45M | Buy |
+60,952
| New | +$3.41M | 0.26% | 86 |
|
|
2024
Q3 | – | Sell |
-324,390
| Closed | -$13.5M | – | 327 |
|
|
2024
Q2 | $13.5M | Buy |
324,390
+309,026
| +2,011% | +$13.8M | 1.47% | 12 |
|
|
2024
Q1 | $833K | Sell |
15,364
-8,250
| -35% | -$420K | 0.05% | 170 |
|
|
2023
Q4 | $1.21M | Buy |
+23,614
| New | +$1.24M | 0.07% | 236 |
|
|
2023
Q3 | – | Sell |
-13,159
| Closed | -$841K | – | 186 |
|
|
2023
Q2 | $841K | Buy |
+13,159
| New | +$882K | 0.08% | 190 |
|
|
2021
Q3 | – | Sell |
-137,230
| Closed | -$9.17M | – | 400 |
|
|
2021
Q2 | $9.17M | Buy |
137,230
+127,939
| +1,377% | +$8.34M | 0.83% | 31 |
|
|
2021
Q1 | $586K | Buy |
+9,291
| New | +$578K | 0.05% | 303 |
|
|
2020
Q4 | – | Sell |
-26,612
| Closed | -$1.6M | – | 464 |
|
|
2020
Q3 | $1.6M | Sell |
26,612
-187,953
| -88% | -$11.3M | 0.14% | 133 |
|
|
2020
Q2 | $12.6M | Buy |
214,565
+47,830
| +29% | +$2.86M | 1.29% | 10 |
|
|
2020
Q1 | $9.29M | Buy |
+166,735
| New | +$10.2M | 1.01% | 15 |
|
|
2019
Q1 | – | Sell |
-184,300
| Closed | -$9.58M | – | 658 |
|
|
2018
Q4 | $9.58M | Buy |
+184,300
| New | +$9.9M | 0.49% | 39 |
|
|
2017
Q4 | – | Sell |
-12,200
| Closed | -$777K | – | 757 |
|
|
2017
Q3 | $777K | Buy |
+12,200
| New | +$712K | 0.01% | 582 |
|
|
2017
Q2 | – | Sell |
-113,100
| Closed | -$6.15M | – | 704 |
|
|
2017
Q1 | $6.15M | Buy |
+113,100
| New | +$6.2M | 0.09% | 290 |
|
|
2016
Q4 | – | Sell |
-209,700
| Closed | -$11.3M | – | 798 |
|
|
2016
Q3 | $11.3M | Buy |
209,700
+115,400
| +122% | +$7.41M | 0.37% | 62 |
|
|
2016
Q2 | $6.93M | Buy |
+94,300
| New | +$6.66M | 0.32% | 77 |
|
|
2016
Q1 | – | Sell |
-20,800
| Closed | -$1.43M | – | 774 |
|
|
2015
Q4 | $1.43M | Buy |
+20,800
| New | +$1.37M | 0.09% | 298 |
|
|
2015
Q2 | – | Sell |
-61,300
| Closed | -$3.95M | – | 471 |
|
|
2015
Q1 | $3.95M | Buy |
+61,300
| New | +$3.84M | 0.38% | 50 |
|
|
2013
Q4 | – | Sell |
-21,700
| Closed | -$1M | – | 575 |
|
|
2013
Q3 | $1M | Sell |
21,700
-155,600
| -88% | -$6.83M | 0.09% | 218 |
|
|
2013
Q2 | $7.92M | Buy |
+177,300
| New | +$7.7M | 1.4% | 8 |
|
Other funds holding BMY
Quantitative Investment Management's BMY Position: Q4 2025 in Review
Quantitative Investment Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 7,635 shares — an estimated $344K sold.
Quantitative Investment Management first reported a position in BMY in Q2 2013 and held it in 21 quarters. The position peaked at $13.5M in Q2 2024. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Quantitative Investment Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Quantitative Investment Management sold 7,635 Bristol-Myers Squibb shares in Q4 2025, an estimated $344K.
- Quantitative Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 21 quarters.
- Quantitative Investment Management's Bristol-Myers Squibb position peaked at $13.5M in Q2 2024.
- 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Quantitative Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.